Stem cell gel takes on acne in new trial

NCT ID NCT07504822

Not yet recruiting Disease control Sponsor: Yohanes Firmansyah, dr, MH, MM Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests three different gels for mild-to-moderate acne: a standard clindamycin-retinoid combo, a clindamycin-retinoid-dexamethasone combo, and a gel made from stem-cell secretions (secretome). About 189 people will use one of the three gels for 8 weeks. Researchers will check if the secretome gel reduces pimples and improves skin quality as well as or better than the other treatments, with fewer side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: stem-cell secretome gel (from human umbilical cord mesenchymal stem cells)
What this could lead to: If it works, this could offer a new, potentially safer topical option for treating mild-to-moderate acne without antibiotics or steroids.
What could go wrong: This is an early-phase (1/2) study with only 189 people, so results may not apply to everyone. The secretome gel is experimental and its long-term safety is unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACNE VULGARIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acne Acne Vulgaris

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACNE VULGARIS

Contacts and locations

Locations

Klinik Precious Me

Tangerang, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.